We are live on ! Find out more
LYRA

LYRA THERAPEUTICS INC

Delisted

LYRA was delisted on the 16th of March, 2026.

57 hedge funds and large institutions have $3.23M invested in LYRA THERAPEUTICS INC in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

75% more call options, than puts

Call options by funds: $7K | Put options by funds: $4K

6% more funds holding

Funds holding: 5457 (+3)

0.04% less ownership

Funds ownership: 0.82%0.78% (-0.04%)

32% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 19

42% less capital invested

Capital invested by funds: $5.54M → $3.23M (-$2.32M)

Holders
57
Holders Change
+3
Holders Change %
+5.56%
% of All Funds
0.76%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
13
Reduced
19
Closed
3
Calls
$7K
Puts
$4K
Net Calls
+$3K
Net Calls Change
-$1K

LYRA Hedge Fund Activity: Q1 2025 in Review

57 of the 7,460 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q1 2025, worth a combined $3.23M — down 42% from $5.54M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new LYRA positions and 3 closed out — a net gain of 3 holders — while 13 added to existing stakes and 19 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $24.3K. The largest seller was Samsara BioCapital, cutting an estimated $108K.

  • 57 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q1 2025, up from 54 in Q4 2024.
  • Funds reported $3.23M of LYRA THERAPEUTICS INC stock for Q1 2025, down 42% quarter-over-quarter.
  • 6 funds opened new LYRA THERAPEUTICS INC positions in Q1 2025 and 3 closed out, a net change of +3 holders.
  • The largest LYRA THERAPEUTICS INC buyer in Q1 2025 was Geode Capital Management, an estimated $24.3K added.
  • The largest LYRA THERAPEUTICS INC seller in Q1 2025 was Samsara BioCapital, an estimated $108K sold.

Based on aggregated 13F filings for Q1 2025.